Brian Roche

531 total citations
36 papers, 372 citations indexed

About

Brian Roche is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Brian Roche has authored 36 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Brian Roche's work include Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (8 papers) and Cardiac Arrhythmias and Treatments (5 papers). Brian Roche is often cited by papers focused on Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (8 papers) and Cardiac Arrhythmias and Treatments (5 papers). Brian Roche collaborates with scholars based in United States, France and United Kingdom. Brian Roche's co-authors include Robert L. Hamlin, Anusak Kijtawornrat, Bruce W. Keene, Denise Saretta Schwartz, Brian D. Guth, Russell Wallis, Noël Dybdal, Thomas W. Beck, Mark Holbrook and David J. Gallacher and has published in prestigious journals such as Life Sciences, Toxicological Sciences and American Journal of Veterinary Research.

In The Last Decade

Brian Roche

32 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Roche United States	12	228	152	52	35	31	36	372
Tetsuya Kitayama Japan	10	195 0.9×	159 1.0×	16 0.3×	23 0.7×	34 1.1×	17	342
Yuji Morikawa Japan	11	41 0.2×	256 1.7×	12 0.2×	22 0.6×	24 0.8×	23	499
Dirk Weisensee Switzerland	10	94 0.4×	213 1.4×	12 0.2×	29 0.8×	24 0.8×	15	454
A Bartorelli Italy	11	217 1.0×	179 1.2×	35 0.7×	24 0.7×	53 1.7×	35	568
Dominique M. Bovée Netherlands	11	121 0.5×	158 1.0×	5 0.1×	91 2.6×	34 1.1×	15	438
Mohammed Alswayyed Saudi Arabia	10	95 0.4×	85 0.6×	10 0.2×	7 0.2×	18 0.6×	31	286
Ian Wakefield United Kingdom	6	140 0.6×	99 0.7×	19 0.4×	2 0.1×	16 0.5×	7	259
John Burkhardt United States	14	468 2.1×	59 0.4×	8 0.2×	9 0.3×	62 2.0×	53	693
Volker B. Fiedler Germany	11	129 0.6×	92 0.6×	7 0.1×	13 0.4×	36 1.2×	54	432
Akhil Bhargava Germany	12	29 0.1×	88 0.6×	27 0.5×	26 0.7×	16 0.5×	20	277

Countries citing papers authored by Brian Roche

Since Specialization

Citations

This map shows the geographic impact of Brian Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Roche more than expected).

Fields of papers citing papers by Brian Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Roche. The network helps show where Brian Roche may publish in the future.

Co-authorship network of co-authors of Brian Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Roche. A scholar is included among the top collaborators of Brian Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Roche. Brian Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koshman, Yevgeniya E., C. Michael Foley, Jennifer Pierson, et al.. (2025). An evaluation of drug-induced blood pressure changes in a standard canine CV safety pharmacology study: A HESI-sponsored consortium. Journal of Pharmacological and Toxicological Methods. 133. 107619–107619.

Leishman, Derek J., et al.. (2024). Demonstrating the statistical and pharmacological sensitivity of nonclinical QTc analysis using a dofetilide dose–response in nonhuman primates. Journal of Pharmacological and Toxicological Methods. 131. 107572–107572. 2 indexed citations

Leishman, Derek J., et al.. (2023). Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates. Journal of Pharmacological and Toxicological Methods. 123. 107299–107299. 6 indexed citations

Leishman, Derek J., et al.. (2023). The “One‐Step” approach for QT analysis increases the sensitivity of nonclinical QTc analysis. Clinical and Translational Science. 16(11). 2253–2264. 9 indexed citations

Rossman, Eric I., Todd Wisialowski, Hugo M. Vargas, et al.. (2023). Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As. Journal of Pharmacological and Toxicological Methods. 123. 107270–107270. 12 indexed citations

Best, Derek, et al.. (2023). Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation. Journal of Pharmacological and Toxicological Methods. 120. 107253–107253. 8 indexed citations

Vargas, Hugo M., Eric I. Rossman, Todd Wisialowski, et al.. (2023). Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute. Journal of Pharmacological and Toxicological Methods. 121. 107265–107265. 13 indexed citations

Ross, J. B. Alexander, Seth Gibbs, Katherine A. B. Knostman, et al.. (2018). Integration of cardiac energetics, function and histology from isolated rat hearts perfused with doxorubicin and doxorubicin-ol; a model for use in drug safety evaluations. Journal of Pharmacological and Toxicological Methods. 94(Pt 2). 54–63. 6 indexed citations

Prior, Helen, Pascal Champéroux, Jason Cordes, et al.. (2016). Social housing of non-rodents during cardiovascular recordings in safety pharmacology and toxicology studies. Journal of Pharmacological and Toxicological Methods. 81. 75–87. 12 indexed citations

10.

Roche, Brian, et al.. (2013). Protein biomarkers of drug-induced cardiotoxicity in the isolated heart: Building a multi-scale approach. Journal of Pharmacological and Toxicological Methods. 68(1). e29–e29. 1 indexed citations

11.

Roche, Brian, et al.. (2013). MMB4 DMS. International Journal of Toxicology. 32(4_suppl). 49S–58S. 3 indexed citations

12.

Beck, Thomas W., Noël Dybdal, David J. Gallacher, et al.. (2011). Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society. Journal of Pharmacological and Toxicological Methods. 65(3). 93–101. 68 indexed citations

13.

Zhao, Lin, et al.. (2008). Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: Effects of early versus delayed treatment. Life Sciences. 82(9-10). 495–502. 28 indexed citations

14.

Roche, Brian, et al.. (2007). THE EFFECTS OF 12-WEEKS OF VENTRICULAR PACING ON CARDIAC PERFORMANCE AND BNP LEVELS IN DOGS. Journal of Pharmacological and Toxicological Methods. 56(2). e12–e12. 1 indexed citations

15.

Kijtawornrat, Anusak, Yoshinori Nishijima, Brian Roche, Bruce W. Keene, & Robert L. Hamlin. (2006). Use of a Failing Rabbit Heart as a Model to Predict Torsadogenicity. Toxicological Sciences. 93(1). 205–212. 19 indexed citations

16.

Roche, Brian, et al.. (2005). Relationship between prolongation of QTc and prolongation of the peak of T (Tp) to the end of T (Te). Journal of Pharmacological and Toxicological Methods. 52(1). 178–181. 8 indexed citations

17.

Kijtawornrat, Anusak, et al.. (2005). Acute cardiovascular effects of tacrolimus in the isolated guinea pig heart. Journal of Veterinary Pharmacology and Therapeutics. 28(3). 313–316. 3 indexed citations

18.

Kijtawornrat, Anusak, et al.. (2005). Assessment of drug-induced QT interval prolongation in conscious rabbits. Journal of Pharmacological and Toxicological Methods. 53(2). 168–173. 12 indexed citations

19.

Hamlin, Robert L., Scott W. Mittelstadt, Anusak Kijtawornrat, et al.. (2003). Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc. Journal of Pharmacological and Toxicological Methods. 49(1). 15–23. 40 indexed citations

20.

Roche, Brian, Denise Saretta Schwartz, Robert A. Lehnhard, et al.. (2002). Changes in concentrations of neuroendocrine hormones and catecholamines in dogs with myocardial failure induced by rapid ventricular pacing. American Journal of Veterinary Research. 63(10). 1413–1417. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact